Evaluating Local Tissue Response

ISO 10993-6 specifies test methods for the assessment of the local effects of a medical device material implanted into living tissue. This evaluation is crucial for any device intended to reside within the human body for any duration.
 

1. Key Objectives of the Test

• Inflammatory Response: To monitor signs of acute or chronic inflammation, such as edema or necrosis at the implant site.

• Capsule Formation: To measure the extent of fibrous tissue development around the device.

• Material Integration: For biodegradable devices, it assesses the rate of resorption and how well the surrounding tissue integrates with the material.
   

2. Selection of Implantation Sites

The choice of site depends on the final clinical application of the device:

• Subcutaneous Implantation: Used for devices that contact the skin or underlying soft tissue.

• Intramuscular Implantation: The most common route for biocompatibility screening of bulk materials.

• Bone Implantation: Reserved for orthopedic or dental implants to evaluate osseointegration.
   

3. The Gold Standard: Histopathological Evaluation

The definitive results of an ISO 10993-6 study rely on Histopathology. Thin sections of the tissue-implant interface are analyzed under a microscope to score the biological response, including the presence of inflammatory cells (neutrophils, macrophages) and the overall health of the surrounding tissue.



Click to Pay